Hypertension is, in Italy, the most common disease encountered by medical practitioners, and the pathological changes produced by elevated arterial pressure are the principal cause of death. 1 Antihypertensive drug therapy reduces the risk of hypertension-related morbidity and mortality; and new drugs, which promise greater efficacy and fewer adverse effects than older drugs, attract physicians. In Italy, the expenditure for antihypertensives reached, in the year 2003, the sum of 991.35 million euro; 2 subtracting from this sum the expenditure due to the use of the same drugs for diseases other than hypertension, that in Italy, is generally estimated to be in the aggregate around 15%, the total expenditure for the therapy of hypertension may be considered to be approximately 840 million euro. The progressively increasing number of subjects potentially eligible to an antihypertensive treatment and the high cost of more recent drugs suggest that both benefit/risk and cost/effectiveness ratios should be carefully considered in the choice of the antihypertensive(s).
The aims of this study were (i) to analyse, in terms of both defined daily doses (DDDs) and expenditure, the use of the various classes of antihypertensive drugs in the Italian Liguria Region during the years 1999-2003; and (ii) to verify to what extent the treatment of hypertensive patients was carried out taking into account the indications of the guidelines. The analysis was based on information provided by the database of the Pharmaceutical Department of the region. The antihypertensive drugs were those included in the following classes of the Anatomic Therapeutic Chemical (ATC) classification of the European Pharmaceutical Market Association: C02-antihypertensives (methyldopa, clonidine, a-adrenergic receptor antagonists, and minoxidil), C03-diuretics, C07-b-adrenergic receptor antagonists, C08-calcium channel antagonists, and C09-drugs acting on the renin-angiotensin system (angiotensin-converting enzyme inhibitors, and angiotensin II-receptor antagonists).
In the year 1999, the inhabitants of the Italian Liguria Region were 1 625 870 (10 Antihypertensive drugs are also prescribed for cardiovascular diseases other than hypertension, for example as antianginal or in congestive heart failure; therefore, even though this alternative use in Italy is estimated to be, in aggregate, around 15%, no definitive conclusions can be drawn from the data listed in Table 1 . However, it seems that the prescribing pattern of the physicians of the Italian Liguria Region does not agree with the indications of most guidelines and of textbooks of clinical pharmacology. The US guidelines 5 state that for uncomplicated hypertension thiazide diuretics should be used in drug treatment for most patients, either alone or combined with drugs of other classes, and delineate specific high-risk conditions that are compelling indications for the use of other antihypertensive drug classes. The British guidelines 6 indicate for each major class of antihypertensive drugs compelling indications, possible indications and compelling contraindications, and, when none of these considerations apply, recommend as firstline drug an ACE-inhibitor or an angiotensin receptor blocker or a b-blocker in people who are younger than 55 years, and a calcium antagonist or a thiazide diuretic for people older than 55 years. The European guidelines 7 state that all major classes of antihypertensive agents are suitable for initiation and maintenance of therapy, affirm that it is likely that a large proportion of patients will require combination therapy with more than one agent, and recommend the inclusion, in these combinations, of an ACE-inhibitor in type 1 diabetes and of an angiotensin receptor antagonist in type 2 diabetes. The WHO guidelines 8 underline that specific agents have benefits for patients with particular compelling indications and that monotherapy is inadequate for the majority of patients, but suggest that a thiazide diuretic should be considered for initiation of therapy in patients without compelling indications for a particular drug class. Finally, it is worth noting that the Current Medical Diagnosis and Treatment 9 states that 'overall, diuretics administered alone control blood pressure in 50% of patients with mild to moderate hypertension and can be used effectively in combination with all other agents'. The prescribing pattern, made evident by this analysis, that indicates that only 2-3% of hypertensive patients were given only a thiazide-type diuretic and only 15-20% were treated with a pharmaceutical preparation containing a diuretic in combination with another antihypertensive drug, certainly does not follow the indication of the guidelines but is also discouraged by the results of two recent studies. The ALLHAT, 10 in patients older than 55 years, provided evidence of the absence of significant differences in the incidence of coronary heart disease and other cardiovascular disease events in three groups of patients treated with chlortalidone, amlodipine, and lisinopril. A metaanalysis 11 of data from 42 clinical trials including 192 478 patients, demonstrates that none of the first-line treatment strategies -beta-blockers, ACEinhibitors, calcium antagonists, alpha-blockers, and angiotensin II antagonists -was significantly better than low-dose diuretics for any outcome.
A possible reason for the questionable prescribing pattern might be the absence in the Italian Liguria Region of local guidelines for the management of hypertension. Since resources are limited and, as a consequence, their best allocation is desirable, a prescription of antihypertensives taking into account also the cost/benefit ratio can be rewarding. In the extreme hypothesis that 50% of the patients might have been treated with chlortalidone, the expenditure would have been reduced by more than 40-45%. We suggest that other studies examine the prescribing pattern of antihypertensive drugs and its pharmacoeconomic implications in other countries (Table 2) . What is known on this topic K The large majority of hypertensive patients are treated with more recent antihypertensive agents without considering the guidelines' indications and the cost/effectiveness ratio. K Recent studies indicate that for uncomplicated hypertension thiazide-type diuretics should be used in drug treatment for most patients, either alone or in combination with drugs of other classes.
What this paper adds K In the Italian Liguria Region, during the years 1999-2003, only the 2-3% of hypertensive patients were given only a thiazidetype diuretic, and only the 15-20% were treated with a pharmaceutical preparation containing a diuretic in combination with another antihypertensive drug. K A prescribing pattern more concordant with the indications of the guidelines might result in a drastic reduction of the expenditure for antihypertensive drugs, and as a consequence in a better allocation of the limited resources available.
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